Hakan Paydak
Concepts (217)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 22 | 2022 | 188 | 5.140 |
Why?
| Defibrillators, Implantable | 8 | 2019 | 66 | 2.680 |
Why?
| Anti-Arrhythmia Agents | 8 | 2020 | 80 | 2.270 |
Why?
| Electrocardiography | 9 | 2021 | 266 | 2.190 |
Why?
| Catheter Ablation | 8 | 2018 | 120 | 1.930 |
Why?
| Arrhythmias, Cardiac | 5 | 2020 | 94 | 1.810 |
Why?
| Tachycardia, Supraventricular | 3 | 2021 | 38 | 1.760 |
Why?
| Hospitalization | 7 | 2022 | 675 | 1.510 |
Why?
| Tachycardia | 3 | 2021 | 28 | 1.200 |
Why?
| Amiodarone | 3 | 2017 | 22 | 1.080 |
Why?
| Heart Rate | 3 | 2021 | 307 | 0.930 |
Why?
| Pacemaker, Artificial | 3 | 2019 | 40 | 0.910 |
Why?
| Vena Cava, Superior | 2 | 2015 | 22 | 0.860 |
Why?
| Anticoagulants | 5 | 2019 | 256 | 0.810 |
Why?
| Humans | 54 | 2023 | 50503 | 0.780 |
Why?
| Tachycardia, Ventricular | 4 | 2020 | 44 | 0.750 |
Why?
| Cardiomyopathy, Dilated | 1 | 2020 | 39 | 0.700 |
Why?
| Hospital Mortality | 5 | 2017 | 413 | 0.690 |
Why?
| Echocardiography, Transesophageal | 1 | 2020 | 61 | 0.690 |
Why?
| Middle Aged | 20 | 2020 | 12611 | 0.650 |
Why?
| Warfarin | 3 | 2019 | 83 | 0.630 |
Why?
| Metoprolol | 1 | 2019 | 13 | 0.630 |
Why?
| Syncope | 2 | 2013 | 29 | 0.610 |
Why?
| Bundle-Branch Block | 2 | 2012 | 18 | 0.600 |
Why?
| Male | 29 | 2022 | 25907 | 0.600 |
Why?
| Heparin | 2 | 2016 | 91 | 0.580 |
Why?
| Heart Failure | 3 | 2019 | 528 | 0.580 |
Why?
| Treatment Outcome | 13 | 2022 | 5283 | 0.560 |
Why?
| Lung Diseases, Interstitial | 1 | 2017 | 24 | 0.550 |
Why?
| Length of Stay | 4 | 2015 | 629 | 0.550 |
Why?
| Hemothorax | 1 | 2016 | 4 | 0.540 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 29 | 0.540 |
Why?
| Cost of Illness | 2 | 2015 | 114 | 0.540 |
Why?
| Heart Conduction System | 2 | 2015 | 23 | 0.540 |
Why?
| Prosthesis Implantation | 1 | 2016 | 47 | 0.520 |
Why?
| Pneumonia | 1 | 2017 | 116 | 0.520 |
Why?
| Wolff-Parkinson-White Syndrome | 1 | 2016 | 7 | 0.520 |
Why?
| Torsades de Pointes | 3 | 2014 | 15 | 0.520 |
Why?
| Propafenone | 1 | 2015 | 2 | 0.500 |
Why?
| Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.500 |
Why?
| Flecainide | 1 | 2015 | 4 | 0.500 |
Why?
| Accessory Atrioventricular Bundle | 1 | 2014 | 3 | 0.480 |
Why?
| Propofol | 1 | 2015 | 21 | 0.480 |
Why?
| Mucolipidoses | 1 | 2014 | 4 | 0.470 |
Why?
| Postoperative Hemorrhage | 1 | 2015 | 52 | 0.470 |
Why?
| Hospital Costs | 1 | 2015 | 72 | 0.470 |
Why?
| Exercise Test | 1 | 2015 | 131 | 0.470 |
Why?
| Electric Countershock | 4 | 2022 | 30 | 0.460 |
Why?
| Heart Ventricles | 3 | 2015 | 265 | 0.460 |
Why?
| Ventricular Dysfunction, Left | 2 | 2015 | 106 | 0.460 |
Why?
| Female | 23 | 2022 | 27081 | 0.450 |
Why?
| Hyponatremia | 1 | 2013 | 11 | 0.440 |
Why?
| Takotsubo Cardiomyopathy | 1 | 2013 | 21 | 0.430 |
Why?
| Patient Safety | 1 | 2014 | 102 | 0.430 |
Why?
| Theophylline | 1 | 2013 | 20 | 0.430 |
Why?
| Health Care Costs | 1 | 2014 | 167 | 0.420 |
Why?
| Therapy, Computer-Assisted | 1 | 2013 | 31 | 0.420 |
Why?
| Vascular Malformations | 1 | 2015 | 102 | 0.410 |
Why?
| Seasons | 1 | 2013 | 79 | 0.410 |
Why?
| Azygos Vein | 1 | 2012 | 11 | 0.400 |
Why?
| Coronary Sinus | 1 | 2012 | 4 | 0.400 |
Why?
| Electrodes, Implanted | 1 | 2012 | 30 | 0.400 |
Why?
| Heart Block | 2 | 2009 | 27 | 0.400 |
Why?
| Superior Vena Cava Syndrome | 1 | 2012 | 11 | 0.400 |
Why?
| Foreign-Body Migration | 1 | 2012 | 32 | 0.400 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 21 | 0.390 |
Why?
| Heart Diseases | 1 | 2014 | 214 | 0.390 |
Why?
| Catheters, Indwelling | 1 | 2012 | 57 | 0.390 |
Why?
| Vena Cava, Inferior | 1 | 2012 | 79 | 0.390 |
Why?
| Cardiac Pacing, Artificial | 1 | 2012 | 33 | 0.390 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 31 | 0.380 |
Why?
| Adult | 15 | 2022 | 13577 | 0.370 |
Why?
| Sinoatrial Node | 1 | 2011 | 3 | 0.370 |
Why?
| Catheterization, Central Venous | 1 | 2012 | 85 | 0.360 |
Why?
| Incidence | 4 | 2019 | 1032 | 0.340 |
Why?
| Retrospective Studies | 10 | 2023 | 6263 | 0.340 |
Why?
| Head and Neck Neoplasms | 1 | 2013 | 287 | 0.330 |
Why?
| Aged | 15 | 2022 | 9741 | 0.330 |
Why?
| Stroke | 3 | 2022 | 495 | 0.330 |
Why?
| Diagnosis, Differential | 5 | 2019 | 1033 | 0.320 |
Why?
| Haloperidol | 1 | 2009 | 47 | 0.310 |
Why?
| Magnetic Resonance Imaging | 2 | 2017 | 1548 | 0.300 |
Why?
| Aged, 80 and over | 7 | 2019 | 3226 | 0.280 |
Why?
| Postoperative Complications | 1 | 2014 | 1033 | 0.270 |
Why?
| Antipsychotic Agents | 1 | 2009 | 233 | 0.270 |
Why?
| Multiple Myeloma | 3 | 2017 | 2998 | 0.270 |
Why?
| Hypertension | 4 | 2019 | 544 | 0.260 |
Why?
| Risk Factors | 7 | 2019 | 3724 | 0.250 |
Why?
| Reproducibility of Results | 3 | 2015 | 1197 | 0.240 |
Why?
| Survival Rate | 2 | 2019 | 909 | 0.230 |
Why?
| Obesity | 1 | 2012 | 1121 | 0.220 |
Why?
| Body Surface Potential Mapping | 1 | 2003 | 1 | 0.210 |
Why?
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.210 |
Why?
| Databases, Factual | 6 | 2017 | 673 | 0.210 |
Why?
| Adolescent | 6 | 2017 | 6443 | 0.210 |
Why?
| Young Adult | 5 | 2017 | 4102 | 0.210 |
Why?
| Arkansas | 3 | 2019 | 1985 | 0.200 |
Why?
| Vagus Nerve Stimulation | 1 | 2022 | 12 | 0.200 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 138 | 0.190 |
Why?
| Time Factors | 6 | 2019 | 2935 | 0.190 |
Why?
| Follow-Up Studies | 2 | 2019 | 2242 | 0.190 |
Why?
| Disease Management | 2 | 2020 | 178 | 0.190 |
Why?
| Telemetry | 1 | 2021 | 29 | 0.180 |
Why?
| Heart Arrest | 1 | 2022 | 155 | 0.170 |
Why?
| Sick Sinus Syndrome | 1 | 2019 | 3 | 0.170 |
Why?
| Hypoventilation | 1 | 2019 | 4 | 0.170 |
Why?
| Recovery of Function | 1 | 2020 | 191 | 0.170 |
Why?
| Sleep Apnea, Central | 1 | 2019 | 12 | 0.160 |
Why?
| Hyperlipidemias | 1 | 2019 | 52 | 0.160 |
Why?
| Diaphragm | 1 | 2019 | 31 | 0.160 |
Why?
| Syndrome | 2 | 2015 | 240 | 0.160 |
Why?
| Antithrombins | 1 | 2019 | 19 | 0.160 |
Why?
| Artifacts | 1 | 2019 | 54 | 0.160 |
Why?
| Diabetes Complications | 1 | 2019 | 116 | 0.160 |
Why?
| Heart Injuries | 1 | 2018 | 15 | 0.150 |
Why?
| Death, Sudden, Cardiac | 1 | 2019 | 57 | 0.150 |
Why?
| Fatty Acids, Omega-3 | 1 | 2018 | 28 | 0.150 |
Why?
| United States | 5 | 2016 | 4955 | 0.150 |
Why?
| Cardiac Surgical Procedures | 1 | 2022 | 313 | 0.150 |
Why?
| Vascular System Injuries | 1 | 2018 | 38 | 0.150 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 108 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2018 | 82 | 0.150 |
Why?
| Cause of Death | 1 | 2019 | 151 | 0.150 |
Why?
| Seizures | 2 | 2022 | 195 | 0.140 |
Why?
| Ventricular Function, Left | 1 | 2019 | 169 | 0.140 |
Why?
| Brain Ischemia | 1 | 2019 | 164 | 0.140 |
Why?
| Hemorrhage | 2 | 2019 | 197 | 0.140 |
Why?
| Comorbidity | 3 | 2014 | 623 | 0.140 |
Why?
| Anti-Inflammatory Agents | 1 | 2018 | 163 | 0.140 |
Why?
| Prednisone | 1 | 2017 | 101 | 0.140 |
Why?
| Accidents, Traffic | 1 | 2017 | 88 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 164 | 0.140 |
Why?
| Ventricular Fibrillation | 2 | 2009 | 16 | 0.130 |
Why?
| Clinical Trials as Topic | 3 | 2018 | 486 | 0.130 |
Why?
| Administration, Oral | 2 | 2019 | 434 | 0.130 |
Why?
| Odds Ratio | 2 | 2015 | 551 | 0.130 |
Why?
| Perioperative Period | 1 | 2016 | 22 | 0.130 |
Why?
| Radiography, Thoracic | 1 | 2016 | 64 | 0.130 |
Why?
| Sex Factors | 2 | 2016 | 712 | 0.130 |
Why?
| Maternal Exposure | 1 | 2017 | 96 | 0.130 |
Why?
| Echocardiography | 2 | 2017 | 400 | 0.130 |
Why?
| Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 5 | 0.120 |
Why?
| Ventricular Function | 1 | 2015 | 20 | 0.120 |
Why?
| Heart Atria | 2 | 2012 | 60 | 0.120 |
Why?
| Vitamin K | 1 | 2015 | 17 | 0.120 |
Why?
| Age Factors | 2 | 2015 | 1110 | 0.120 |
Why?
| Glucocorticoids | 1 | 2017 | 230 | 0.120 |
Why?
| Anesthetics, Intravenous | 1 | 2015 | 22 | 0.120 |
Why?
| Insurance, Health | 1 | 2016 | 128 | 0.120 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2015 | 573 | 0.120 |
Why?
| Forecasting | 1 | 2015 | 147 | 0.120 |
Why?
| Infusions, Intravenous | 1 | 2015 | 213 | 0.120 |
Why?
| Thromboembolism | 1 | 2015 | 55 | 0.120 |
Why?
| Health Planning | 1 | 2014 | 14 | 0.120 |
Why?
| Fatal Outcome | 1 | 2015 | 197 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 266 | 0.110 |
Why?
| Hematologic Neoplasms | 1 | 2015 | 99 | 0.110 |
Why?
| Fibrinolytic Agents | 1 | 2015 | 125 | 0.110 |
Why?
| Cardiomyopathies | 1 | 2015 | 120 | 0.110 |
Why?
| Radiography | 1 | 2015 | 485 | 0.110 |
Why?
| Ultrasonography | 2 | 2012 | 435 | 0.110 |
Why?
| Methadone | 1 | 2014 | 183 | 0.110 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2013 | 44 | 0.100 |
Why?
| Vasodilator Agents | 1 | 2013 | 100 | 0.100 |
Why?
| Health Care Surveys | 1 | 2013 | 175 | 0.100 |
Why?
| Bradycardia | 1 | 2012 | 37 | 0.100 |
Why?
| Healthcare Disparities | 1 | 2016 | 281 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2017 | 461 | 0.100 |
Why?
| Angioplasty | 1 | 2012 | 20 | 0.100 |
Why?
| After-Hours Care | 1 | 2012 | 12 | 0.100 |
Why?
| Mitral Valve | 1 | 2012 | 50 | 0.100 |
Why?
| Prevalence | 1 | 2015 | 971 | 0.100 |
Why?
| Angiography | 1 | 2012 | 128 | 0.100 |
Why?
| Phlebography | 1 | 2012 | 60 | 0.100 |
Why?
| Device Removal | 1 | 2012 | 85 | 0.100 |
Why?
| Patient Admission | 1 | 2012 | 76 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 978 | 0.090 |
Why?
| Subarachnoid Hemorrhage | 1 | 2012 | 65 | 0.090 |
Why?
| Disease Progression | 1 | 2014 | 829 | 0.090 |
Why?
| Stem Cell Transplantation | 1 | 2012 | 179 | 0.090 |
Why?
| Hospitals | 2 | 2023 | 173 | 0.090 |
Why?
| Patient Discharge | 1 | 2013 | 321 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 859 | 0.090 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 578 | 0.090 |
Why?
| Dextrocardia | 1 | 2009 | 4 | 0.080 |
Why?
| Pregnancy | 1 | 2017 | 2452 | 0.080 |
Why?
| Algorithms | 1 | 2013 | 625 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2014 | 1610 | 0.080 |
Why?
| Kidney Failure, Chronic | 1 | 2009 | 201 | 0.070 |
Why?
| Cardiac Catheterization | 1 | 2009 | 223 | 0.070 |
Why?
| Inpatients | 2 | 2022 | 193 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2012 | 1164 | 0.070 |
Why?
| Magnetics | 1 | 2003 | 35 | 0.050 |
Why?
| Vagus Nerve | 1 | 2022 | 22 | 0.050 |
Why?
| Electrodes | 1 | 2022 | 35 | 0.050 |
Why?
| Animals | 2 | 2018 | 13124 | 0.050 |
Why?
| Logistic Models | 2 | 2012 | 900 | 0.040 |
Why?
| Drug Utilization | 1 | 2019 | 76 | 0.040 |
Why?
| Motor Vehicles | 1 | 2017 | 15 | 0.040 |
Why?
| Databases, Bibliographic | 1 | 2016 | 15 | 0.030 |
Why?
| Heparin, Low-Molecular-Weight | 1 | 2016 | 21 | 0.030 |
Why?
| Medically Uninsured | 1 | 2016 | 45 | 0.030 |
Why?
| Heart | 1 | 2017 | 341 | 0.030 |
Why?
| Safety | 1 | 2015 | 77 | 0.030 |
Why?
| Risk | 1 | 2015 | 324 | 0.030 |
Why?
| Age Distribution | 1 | 2013 | 170 | 0.030 |
Why?
| Systole | 1 | 2012 | 72 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2013 | 930 | 0.020 |
Why?
| Child | 1 | 2003 | 6906 | 0.020 |
Why?
| Transplantation, Autologous | 1 | 2012 | 481 | 0.020 |
Why?
| Kidney Diseases | 1 | 2012 | 213 | 0.020 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 393 | 0.020 |
Why?
| Situs Inversus | 1 | 2009 | 3 | 0.020 |
Why?
| Prospective Studies | 1 | 2015 | 2378 | 0.020 |
Why?
| Risk Assessment | 1 | 2012 | 1270 | 0.020 |
Why?
| Kidney | 1 | 2012 | 696 | 0.020 |
Why?
| Coronary Angiography | 1 | 2009 | 359 | 0.020 |
Why?
|
|
Paydak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|